CYLD and ovarian cancer: Interestingly, a study by Xu et al. [73] reported that the use of anti-miR-182 was able to restore the expression of several cell-cycle genes, including Cyld and Foxo1, in a mouse model of an orthotopic ovarian cancer xenograft.